Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 70
Filter
1.
BMJ Case Rep ; 14(4)2021 Apr 13.
Article in English | MEDLINE | ID: mdl-33849864

ABSTRACT

The COVID-19 pandemic caused by the SARS-CoV-2 virus has affected millions of people around the globe. The most common presentation of COVID-19 is fever and upper and lower respiratory tract infection. Myalgia is fairly common in the prodromal phase of the viral illness which self-resolves. There is very scant literature on autoimmune myositis triggered by COVID-19 infection. We report a case of SARS-CoV-2 infection, who presented with progressive muscle weakness with rhabdomyolysis and necrotizing autoimmune myopathy on muscle biopsy. This case report imposes awareness of musculoskeletal autoimmune processes triggered by COVID-19 which requires clinical suspicion for early diagnosis and initiation of treatment.


Subject(s)
Autoimmune Diseases/virology , COVID-19/complications , Myositis/virology , Antibodies, Viral/blood , Autoimmune Diseases/therapy , Diagnosis, Differential , Female , Humans , Immunoglobulin G/blood , Middle Aged , Muscle Weakness/virology , Myalgia/virology , Myositis/therapy , Necrosis/virology , Prednisone/therapeutic use , Rhabdomyolysis/virology
2.
Eur J Phys Rehabil Med ; 57(3): 434-442, 2021 06.
Article in English | MEDLINE | ID: mdl-33448757

ABSTRACT

BACKGROUND: The risk of muscle weakness is high in the survivors of acute respiratory distress syndrome with COVID-19 following discharge from intensive care unit. AIM: To evaluate the effects of early rehabilitation program in intensive care unit in patients with acute respiratory distress syndrome secondary to COVID-19. DESIGN: The design of the study is observational. SETTING: The setting of the study is inpatient. POPULATION: Thirty-five patients with acute respiratory distress syndrome secondary to COVID-19 were enrolled. METHODS: This study was performed in an intensive care unit of a university hospital. Early rehabilitation program consisting of passive or active range of motion exercises and neuromuscular electrical stimulation in addition to standard intensive care (N.=18) compared to standard intensive care (N.=17). Primary outcome was hand grip strength following discharge. RESULTS: Rehab group had higher prevalence of chronic pulmonary diseases and neurologic diseases. There was no difference in hand grip or manual muscle strength following discharge between rehab and non-rehab groups. No adverse event was noted. CONCLUSIONS: The results did not support the beneficial effects of early rehabilitation in intensive care unit on improving muscle strength. More patients with pulmonary and neurologic diseases in rehab group might impede the impact of rehabilitation on outcomes. On the other hand, these comorbidities underline the role and need of rehabilitation. It is safe both for the patients and the health care workers when necessary precautions are taken. CLINICAL REHABILITATION IMPACT: This study guide how to rehabilitate patients with acute respiratory distress syndrome with COVID-19 during intensive care unit in a safe way.


Subject(s)
COVID-19/complications , Muscle Weakness/therapy , Muscle Weakness/virology , Physical Therapy Modalities , Respiratory Distress Syndrome/therapy , Respiratory Distress Syndrome/virology , Aged , Aged, 80 and over , Female , Humans , Intensive Care Units , Male , Middle Aged , Pandemics , Pneumonia, Viral/therapy , Pneumonia, Viral/virology , SARS-CoV-2
4.
Article in English | MEDLINE | ID: mdl-33255233

ABSTRACT

The COVID-19 pandemic has recently been the cause of a global public health emergency. Frequently, elderly patients experience a marked loss of muscle mass and strength during hospitalization, resulting in a significant functional decline. This paper describes the impact of prolonged immobilization and current pharmacological treatments on muscular metabolism. In addition, the scientific evidence for an early strength intervention, neuromuscular electrical stimulation or the application of heat therapy during hospitalization to help prevent COVID-19 functional sequels is analyzed. This review remarks the need to: (1) determine which potential pharmacological interventions have a negative impact on muscle quality and quantity; (2) define a feasible and reliable pharmacological protocol to achieve a balance between desired and undesired medication effects in the treatment of this novel disease; (3) implement practical strategies to reduce muscle weakness during bed rest hospitalization and (4) develop a specific, early and safe protocol-based care of functional interventions for older adults affected by COVID-19 during and after hospitalization.


Subject(s)
COVID-19/epidemiology , Hospitalization , Muscle Weakness , Aged , COVID-19/physiopathology , Humans , Muscle Weakness/epidemiology , Muscle Weakness/virology , Pandemics , Time Factors
5.
Scott Med J ; 65(4): 127-132, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32807018

ABSTRACT

BACKGROUND: The first case of a novel coronavirus (COVID-19) infection was detected in Wuhan, fever and respiratory symptoms have been frequently reported in patients infected with this virus. AIM: It was aimed to compare the symptoms of patients with COVID-19 positivity and patients without COVID-19 positivity hospitalized with suspicion of COVID-19. METHODS: Patients presenting to the Sakarya University Training and Research Hospital with suspicion of COVID-19 were included in the study. Samples were obtained from the patients and PCR tests were performed; the patients were grouped as COVID-19 positive and COVID-19 negative; these two groups were questioned for 15 symptoms and the results were compared. RESULTS: A total of 297 patients with suspicion of COVID-19 were included in the study. COVID-19 was positive in 143 patients and negative in 154 patients. The most common symptoms in the COVID-19 positive group were: cough (56.6%), weakness (56.6%), taste disorder (35.7%), myalgia (34.3%), and fever (33.6%); and in the COVID-19 negative group: cough (63%), weakness (45.5%), dyspnea (29.9%), headache (27.3%) and fever (24.7%). When these two groups were compared, taste disorder, smell disorder and diarrhea were significantly higher in the COVID-19 positive group (p = <0,00001, p = 0,00001 and p = 0,02). CONCLUSION: Our study showed that taste and smell disorders and diarrhea were important markers in COVID-19 infection.


Subject(s)
Betacoronavirus , Coronavirus Infections/complications , Coronavirus Infections/diagnosis , Pneumonia, Viral/complications , Pneumonia, Viral/diagnosis , Aged , Aged, 80 and over , COVID-19 , Coronavirus Infections/therapy , Cough/epidemiology , Cough/virology , Diarrhea/epidemiology , Diarrhea/virology , Female , Fever/epidemiology , Fever/virology , Hospitalization , Humans , Male , Middle Aged , Muscle Weakness/epidemiology , Muscle Weakness/virology , Myalgia/epidemiology , Myalgia/virology , Olfaction Disorders/epidemiology , Olfaction Disorders/virology , Pandemics , Pneumonia, Viral/therapy , Retrospective Studies , SARS-CoV-2 , Symptom Assessment , Taste Disorders/epidemiology , Taste Disorders/virology , Turkey
7.
J Bone Joint Surg Am ; 102(14): 1197-1204, 2020 07 15.
Article in English | MEDLINE | ID: mdl-32675661

ABSTRACT

Coronavirus disease 2019 (COVID-19) is an emerging pandemic disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although the majority of patients who become infected with SARS-CoV-2 are asymptomatic or have mild symptoms, some patients develop severe symptoms that can permanently detract from their quality of life. SARS-CoV-2 is closely related to SARS-CoV-1, which causes severe acute respiratory syndrome (SARS). Both viruses infect the respiratory system, and there are direct and indirect effects of this infection on multiple organ systems, including the musculoskeletal system. Epidemiological data from the SARS pandemic of 2002 to 2004 identified myalgias, muscle dysfunction, osteoporosis, and osteonecrosis as common sequelae in patients with moderate and severe forms of this disease. Early studies have indicated that there is also considerable musculoskeletal dysfunction in some patients with COVID-19, although long-term follow-up studies have not yet been conducted. The purpose of this article was to summarize the known musculoskeletal pathologies in patients with SARS or COVID-19 and to combine this with computational modeling and biochemical signaling studies to predict musculoskeletal cellular targets and long-term consequences of the SARS-CoV-2 infection.


Subject(s)
Coronavirus Infections/complications , Musculoskeletal System/physiopathology , Pneumonia, Viral/complications , Angiotensin-Converting Enzyme 2 , Betacoronavirus , Bone and Bones/physiopathology , COVID-19 , Computer Simulation , Humans , Joints/physiopathology , Muscle Weakness/virology , Muscle, Skeletal/physiopathology , Myalgia/virology , Pandemics , Peptidyl-Dipeptidase A/genetics , SARS-CoV-2 , Serine Endopeptidases/genetics
10.
J Med Case Rep ; 13(1): 120, 2019 May 02.
Article in English | MEDLINE | ID: mdl-31043165

ABSTRACT

BACKGROUND: Although dengue viral infections have emerged as one of the most important mosquito-borne diseases, neurological manifestations of dengue infections are uncommon. Guillain-Barré syndrome and Miller Fisher syndrome have been reported to occur as immune-mediated complications following dengue infection. We report the case of a patient who developed Miller Fisher syndrome during the acute phase of dengue fever suggesting that Miller Fisher syndrome may arise as a result of direct neurotropism of the dengue virus. CASE PRESENTATION: A 70-year-old Sri Lankan man with well-controlled diabetes mellitus and hypertension presented with fever of 3 days' duration, drooping of eyelids, dysarthria, and unsteady gait. He developed bilateral asymmetric partial ptosis, complete external ophthalmoplegia, bilateral palatal palsy, unilateral tongue weakness, ataxia, and areflexia from the second day of illness. He did not have limb weakness. He had evidence of acute dengue infection including progressive thrombocytopenia and leukopenia, positive dengue non-structural protein 1 antigen, dengue immunoglobulin M antibodies, and polymerase chain reaction detection of dengue virus genome in serum. Magnetic resonance imaging of his brain and cerebrospinal fluid analysis were normal. Polymerase chain reaction for dengue virus and immunoglobulin M antibodies in cerebrospinal fluid were negative. Nerve conduction studies showed axonal neuropathy. Antibodies (immunoglobulin G, immunoglobulin M, and immunoglobulin A) against GQ1b and GT1a were negative. He was treated with intravenously administered immunoglobulins and a recommended fluid regimen for dengue fever. He made a complete recovery from dengue fever in 7 days and Miller Fisher syndrome in 20 days. CONCLUSIONS: This case report highlights the rare occurrence of Miller Fisher syndrome during the acute phase of dengue fever. Neurological manifestations may occur as a consequence of direct neurotropism of dengue virus.


Subject(s)
Dengue/diagnosis , Immunoglobulins, Intravenous/therapeutic use , Immunologic Factors/therapeutic use , Miller Fisher Syndrome/diagnosis , Ophthalmoplegia/diagnosis , Aged , Arthralgia/etiology , Arthralgia/virology , Dengue/complications , Dengue/physiopathology , Diplopia/virology , Fever/virology , Humans , Male , Miller Fisher Syndrome/etiology , Miller Fisher Syndrome/physiopathology , Muscle Weakness/virology , Ophthalmoplegia/etiology , Ophthalmoplegia/virology , Treatment Outcome
11.
Am J Emerg Med ; 37(3): 564.e5-564.e6, 2019 03.
Article in English | MEDLINE | ID: mdl-30583817

ABSTRACT

Cranial polyneuropathy is commonly caused by Lyme disease. We discuss the case of a man who presented with cranial nerve deficits causing dysphagia, dysphonia and facial weakness. This diagnostic dilemma stemmed from a workup that ruled out Lyme and vascular causes leading to an expanded search for infectious explanations, which revealed varicella zoster in the cerebrospinal fluid. On review, this phenomenon is rarely reported, but has been observed with a number of herpes family viruses. In emergency department settings, clinical suspicion should be raised for VZV infection even in the absence of rash in patients that present with multiple cranial nerve palsies.


Subject(s)
Cranial Nerve Diseases/virology , Herpes Zoster/diagnosis , Polyneuropathies/virology , Acyclovir/therapeutic use , Antiviral Agents/therapeutic use , Deglutition Disorders/virology , Dysphonia/virology , Emergency Service, Hospital , Facial Muscles/virology , Herpes Zoster/cerebrospinal fluid , Herpes Zoster/drug therapy , Herpesvirus 3, Human/isolation & purification , Humans , Male , Middle Aged , Muscle Weakness/virology
12.
BMC Infect Dis ; 18(1): 685, 2018 Dec 20.
Article in English | MEDLINE | ID: mdl-30572825

ABSTRACT

BACKGROUND: The emerging avian influenza A (H7N9) virus, a subtype of influenza viruses, was first discovered in March 2013 in China. Infected patients frequently present with pneumonia and acute respiratory disorder syndrome with high rates of intensive care unit admission and death. Neurological complications, such as Guillain-Barré syndrome(GBS), and intensive care unit-acquired weakness, including critical illness polyneuropathy and myopathy, have only rarely been reported previously. CASE PRESENTATION: In this study, we report on two Chinese patients with H7N9 severe pneumonia presenting neurological complications. These two patients had non-immune diseases prior to the onset of virus infection. A 56-year-old female patient (case 1) and a 78-year-old female patient (case 2) were admitted because of fever, cough, chest tightness and shortness of breath. These patients were confirmed to have H7N9 infection soon after admission followed by the development of acute respiratory distress syndrome and various severe bacterial and fungal infections. The case 1 patient was found to have muscle weakness in all extremities after withdrawing the mechanical ventilator, and the case 2 patient was found when withdrawing extracorporeal membrane oxygenation, both of these conditions prolonged ventilator-weaning time. Furthermore, the case 1 patient carried the H7N9 virus for a prolonged period, reaching 28 days, and both of them stayed in the hospital for more than two months. A clinical diagnosis of intensive care unit-acquired weakness could be confirmed. However, based on results from electrophysiological testing and needle electromyography of these 2 patients, it is difficult to differentiate critical illness polyneuropathy from GBS, since no lumbar puncture or muscle and nerve biopsy were conducted during hospitalization. Following a long-term comprehensive treatment, the patients' neurological condition improved gradually. CONCLUSIONS: Although there is great improvement in saving severe patients' lives from fatal respiratory and blood infections, it is necessary to pay sufficient attention and to use more methods to differentiate GBS from intensive care unit-acquired weakness. This unusual neurological complication could result in additional complications including ventilator associated pneumonia, prolonged hospital stay and then would further increase the death rate, and huge costs.


Subject(s)
Influenza A Virus, H7N9 Subtype/physiology , Influenza, Human/complications , Muscle Weakness/virology , Aged , China , Extracorporeal Membrane Oxygenation , Female , Humans , Influenza A Virus, H7N9 Subtype/isolation & purification , Influenza, Human/pathology , Influenza, Human/therapy , Influenza, Human/virology , Intensive Care Units , Male , Middle Aged , Muscle Weakness/pathology , Pneumonia, Viral/complications , Pneumonia, Viral/pathology , Pneumonia, Viral/therapy , Respiratory Distress Syndrome/complications , Respiratory Distress Syndrome/therapy , Respiratory Distress Syndrome/virology
13.
J Pediatric Infect Dis Soc ; 7(4): 350-354, 2018 Dec 03.
Article in English | MEDLINE | ID: mdl-29373673

ABSTRACT

Human T-cell lymphotropic virus (HTLV), an infection that is endemic in certain parts of Asia, Africa, and South America, has been associated with malignancy and neurological deficits. Here, we describe a pediatric patient with chronic HTLV-I infection who developed complications associated with HTLV-I (ie, adult T-cell leukemia/lymphoma and HTLV-I-associated myelopathy/tropical spastic paraparesis). To our knowledge, this presentation in a child has never been described. The patient underwent a bone marrow transplant and, at the time of this writing, was in remission. This case report highlights the fact that HTLV-related complications, previously expected to occur after decades of infection, also can occur in pediatric patients, particularly those who acquired HTLV-I perinatally.


Subject(s)
Bell Palsy/virology , Deltaretrovirus Infections/diagnosis , Hearing Loss, Bilateral/virology , Muscle Weakness/virology , Skull/pathology , Adolescent , Antiviral Agents/therapeutic use , Bone Marrow Transplantation , Chronic Disease , Cranial Irradiation , Deltaretrovirus Infections/complications , Deltaretrovirus Infections/pathology , Deltaretrovirus Infections/therapy , Diagnosis, Differential , Endemic Diseases , Humans , Leg , Male , Radiography , Skull/diagnostic imaging , Tomography, X-Ray Computed
15.
Pract Neurol ; 17(6): 479-481, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28819047

ABSTRACT

A 35-year-old man presented with myalgia and bilateral hand weakness, 3 days after the onset of lethargy, fevers and rigours. The hand weakness caused functional impairment including difficulty pressing keys on his mobile phone. On examination, there was mild bilateral hand weakness with normal reflexes. His serum creatine kinase was mildly raised at 503 U/L (24-195), viral PCR throat swab was negative and electromyogram showed subtle myopathic changes in the distal forearm muscles. Nerve conduction studies found no evidence of neuropathy. Forced vital capacity was reduced on admission (1.5 L) but improved within 24 hours (2.3 L). We gave supportive intravenous fluids and his weakness improved within 48 hours. He was discharged and reported that the weakness had fully resolved within weeks. The diagnosis was viral myositis. Distal forearm myositis rarely follows H1N1 influenza in adults but is an important differential for postinfective neurological symptoms.


Subject(s)
Influenza, Human/complications , Muscle Weakness/virology , Myositis/virology , Adult , Hand , Humans , Influenza A Virus, H1N1 Subtype , Male
18.
J Emerg Med ; 49(3): 274-6, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26095222

ABSTRACT

BACKGROUND: Weakness is a common presentation in the emergency department (ED). Asymmetric weakness or weakness that appears not to follow an anatomical pattern is a less common occurrence. Acute flaccid paralysis with no signs of meningoencephalitis is one of the more uncommon presentations of West Nile virus (WNV). Patient may complain of an acute onset of severe weakness, or even paralysis, in one or multiple limbs with no sensory deficits. This weakness is caused by injury to the anterior horn cells of the spinal cord. We present a case of acute asymmetric flaccid paralysis with preserved sensory responses that was eventually diagnosed as neuroinvasive WNV infection. CASE REPORT: A 31-year-old male with no medical history presented with complaints of left lower and right upper extremity weakness. Computed tomography scan was negative and multiple other studies were performed in the ED. Eventually, he was admitted to the hospital and was found to have decreased motor amplitudes, severely reduced motor neuron recruitment, and denervation on electrodiagnostic study. Cerebrospinal fluid specimen tested positive for WNV immunoglobulin (Ig) G and IgM antibodies. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: Acute asymmetric flaccid paralysis with no signs of viremia or meningoencephalitis is an unusual presentation of WNV infection. WNV should be included in the differential for patients with asymmetric weakness, especially in the summer months in areas with large mosquito populations.


Subject(s)
Muscle Weakness/physiopathology , Muscle Weakness/virology , West Nile Fever/complications , Acute Disease , Adult , Diagnosis, Differential , Humans , Male , West Nile virus/pathogenicity
19.
Scott Med J ; 60(2): e27-9, 2015 May.
Article in English | MEDLINE | ID: mdl-25663032

ABSTRACT

Hepatitis E virus infection is an emerging disease in developed countries. Acute and chronic infection has been reported, with chronic infection being increasingly reported in immunocompromised patients. Neurological disorders are an emerging manifestation of both acute and chronic hepatitis E virus infection. We report a 77-year-old female presented with paraesthesia and was found to have abnormal liver function tests. Serology was found to be positive for hepatitis E virus IgM, IgG and RNA. Liver function tests normalised after three weeks and her neurological symptoms completely resolved. To our knowledge, this is the first case in Scotland of hepatitis E virus presenting only with neurological symptoms.


Subject(s)
Hepatitis E virus/isolation & purification , Hepatitis E/complications , Hepatitis E/diagnosis , Muscle Weakness/virology , Paresthesia/virology , Aged , Female , Hepatitis E/metabolism , Hepatitis E virus/genetics , Hepatitis E virus/immunology , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Liver Function Tests , RNA, Viral/blood , Scotland , Treatment Outcome
20.
Skeletal Radiol ; 43(10): 1481-5, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24880713

ABSTRACT

Herpes zoster is a common disorder characterized by a painful rash along a dermatome caused by reactivation of the varicella zoster virus (VZV). Muscle denervation injury from motor involvement is an uncommon phenomenon. Discordant distribution of the skin rash and motor nerve involvement, presenting as a skin rash in one body part and muscle weakness or pain from nerve involvement in another body part is an even more uncommonly reported finding. We present an unusual case of muscle denervation injury resulting from motor involvement of a peripheral nerve by VZV diagnosed by magnetic resonance imaging with cutaneous manifestations in a different dermatomal distribution. To the best of our knowledge, there has been no similar case reported in the English radiology literature. We suggest that whenever a radiologist notices MRI findings suggesting denervation injury and a cause not readily identified, VZV-related denervation injury should be included in the differential diagnosis, especially in an older immunocompromised patient.


Subject(s)
Exanthema/virology , Herpes Zoster/complications , Magnetic Resonance Imaging/methods , Muscular Diseases/diagnosis , Shoulder Joint/innervation , Shoulder Joint/pathology , Antiviral Agents/therapeutic use , Diagnosis, Differential , Herpes Zoster/drug therapy , Humans , Immunocompromised Host , Male , Middle Aged , Muscle Weakness/pathology , Muscle Weakness/virology , Muscular Diseases/virology , Shoulder Joint/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...